Mark D Shewczyk, MD | |
2061 Cheyenne Ct, Grafton, WI 53024-9368 | |
(262) 376-1934 | |
Not Available |
Full Name | Mark D Shewczyk |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 41 Years |
Location | 2061 Cheyenne Ct, Grafton, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609809672 | NPI | - | NPPES |
31700100 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 28080 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Columbia St Marys Hospital Milwaukee Inc | 5890604722 | 279 |
News Archive
PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired American Billing Services (ABS) of Portland, Oregon, expanding the operations and geographical footprint of PracticeMax in the northwestern United States.
Transsexual individuals who identify themselves as such in the workplace are more likely to have greater satisfaction and commitment to their job than transsexuals who do not, according to a new study from Rice University and Pennsylvania State University.
Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
› Verified 7 days ago
Entity Name | Columbia St Marys Hospital Milwaukee Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired American Billing Services (ABS) of Portland, Oregon, expanding the operations and geographical footprint of PracticeMax in the northwestern United States.
Transsexual individuals who identify themselves as such in the workplace are more likely to have greater satisfaction and commitment to their job than transsexuals who do not, according to a new study from Rice University and Pennsylvania State University.
Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mark D Shewczyk, MD 2061 Cheyenne Ct, Grafton, WI 53024-9368 Ph: (262) 376-1934 | Mark D Shewczyk, MD 2061 Cheyenne Ct, Grafton, WI 53024-9368 Ph: (262) 376-1934 |
News Archive
PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired American Billing Services (ABS) of Portland, Oregon, expanding the operations and geographical footprint of PracticeMax in the northwestern United States.
Transsexual individuals who identify themselves as such in the workplace are more likely to have greater satisfaction and commitment to their job than transsexuals who do not, according to a new study from Rice University and Pennsylvania State University.
Anika Therapeutics, Inc. today announced it has received marketing approval for MONOVISC from the U.S. Food and Drug Administration. MONOVISC is a single injection supplement to synovial fluid of the osteoarthritic joint, used to treat pain and improve joint mobility in patients suffering from osteoarthritis (OA) of the knee.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
› Verified 7 days ago
Lauren Weasler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Cheyenne Ct, Grafton, WI 53024 Phone: 262-376-1934 | |
Lester Ferra, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 Port Washington Rd, Grafton, WI 53024 Phone: 262-329-1000 | |
Dr. Jaime Diaz Cabatingan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Cheyenne Ct, Grafton, WI 53024 Phone: 262-376-1934 Fax: 262-375-2076 | |
Adam Peter Calusic, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Washington St, Grafton, WI 53024 Phone: 262-375-3700 Fax: 262-375-6306 |